PFE 250502 12.00P(PFE250502P12000) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PFE250502P12000

Watchlist

0.02
0.000.00%

15min DelayTrading Apr 16 10:16 ET

0.00High0.00Low

Intraday

5D
Daily

News

Pfizer 1Q Revenue Slides as Paxlovid Sales Fade
WSJ07:09 ET
4 Stocks to Watch on Tuesday: KO, PFE, GM and UPS
Seeking Alpha26minutes ago
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday
MT Newswires35minutes ago
News Highlights: Top Company News of the Day - Tuesday at 9 AM ET
Dow Jones47minutes ago
Pfizer Sticks to 2025 Profit View as It Shrugs off Plunging Paxlovid Sales for COVID
MarketWatch08:46 ET
Weight loss drugs "fail" while cost-cutting efforts "save the situation", Pfizer (PFE.US) Q1 profits exceed expectations but revenue declines.
On Tuesday, Pfizer (PFE.US) released its first-quarter performance before the market opened, intensifying cost-cutting efforts this quarter, with profits exceeding market expectations.
Zhitong Finance08:42 ET

Comments

BC_76

4 hours ago

7 percent yield from dividends, making history.

$Pfizer (PFE.US)$ time for the bounce tonight?

105754083

Yesterday 17:32

$Pfizer (PFE.US)$ what will the financial result gonna be today?

Teddy123

Yesterday 10:51

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

$Pfizer (PFE.US)$
Breakthrough: Pfizer's New Bladder Cancer Treatment First Major Advance in 30 Years - See 91% Success Rate

Deep Sea

Yesterday 10:22

$Pfizer (PFE.US)$
Pfizer (PFE) announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody, in combination with standard of care Bacillus Calmette-Guerin as induction therapy with or without maintenance in patients with BCG-naive, high-risk non-muscle invasive bladder cancer, NMIBC. The trial met its primary endpoint of event-free survival, EFS, by investigator assessment, demonstrating a clinically meaningful and statistically significan...

搞经济抄底加仓

Apr 27 06:31

I'm just thinking if FDA, WHO, and them are together in this.. ? whatever cancer cure and other cure forever stop at 50% to 85% and they will change to another new treatment and then 50% to 85% and repeat.. seriously, is 2025 already they think we're still living in 1925 when all people don't go to school?
get done once, just once a 100%
$Johnson & Johnson (JNJ.US)$
$Pfizer (PFE.US)$
$E-mini NASDAQ 100 Futures(JUN5) (NQmain.US)$
$E-mini S&P 500 Futures(JUN5) (ESmain.US)$